Health care stocks fell Monday afternoon, with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.1%.
The iShares Biotechnology ETF (IBB) shed 0.3%.
In corporate news, BioNTech (BNTX) shares dropped 2.7% after the company reported an unexpected decline in Q1 sales.
Capricor Therapeutics (CAPR) shares tumbled past 10% after the company said the US Food and Drug Administration plans to hold an advisory committee meeting to review its biologics license application for deramiocel, an investigational cell therapy for treating cardiomyopathy in Duchenne muscular dystrophy patients.
Rezolute (RZLT) shares popped 2.9% after the company said the FDA granted breakthrough therapy designation for ersodetug, an investigational treatment for hypoglycemia caused by tumor hyperinsulinism.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。